View in EDS

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.

Saved in:
Bibliographic Details
Title: ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Authors: Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Lemvigh CK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Dangle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU-Nancy, Service d'hématologie Biologique, Pôle Laboratoires, 54000 Nancy, France., Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France., Guièze R; CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France; EA 7453 (CHELTER), Université Clermont Auvergne, 63001 Clermont-Ferrand, France., Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Long JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA 02115, USA., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Werner L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Anandappa A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Gohil S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA., Bachireddy P; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shukla SA; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Khoury JD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Thakral B; Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Tam C; Alfred Health, Melbourne, VIC, Australia; Monash University, Melbourne, VIC, Australia., Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France., Kharchenko P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02215, USA., Wierda W; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Olsen LR; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Jain N; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: Catherine_wu@dfci.harvard.edu.
Source: Cancer cell [Cancer Cell] 2023 Oct 09; Vol. 41 (10), pp. 1803-1816.e8. Date of Electronic Publication: 2023 Sep 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37738974
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ZNF683 marks a CD8<superscript>+</superscript> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parry+EM%22">Parry EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Lemvigh+CK%22">Lemvigh CK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Deng+S%22">Deng S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Dangle+N%22">Dangle N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Ruthen+N%22">Ruthen N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Knisbacher+BA%22">Knisbacher BA</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Broséus+J%22">Broséus J</searchLink>; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU-Nancy, Service d'hématologie Biologique, Pôle Laboratoires, 54000 Nancy, France.<br /><searchLink fieldCode="AU" term="%22Hergalant+S%22">Hergalant S</searchLink>; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France.<br /><searchLink fieldCode="AU" term="%22Guièze+R%22">Guièze R</searchLink>; CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France; EA 7453 (CHELTER), Université Clermont Auvergne, 63001 Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+C%22">Johnson C</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Long+JM%22">Long JM</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Yin+S%22">Yin S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Werner+L%22">Werner L</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Anandappa+A%22">Anandappa A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Purroy+N%22">Purroy N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Gohil+S%22">Gohil S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Oliveira+G%22">Oliveira G</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Bachireddy+P%22">Bachireddy P</searchLink>; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+SA%22">Shukla SA</searchLink>; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Huang+T%22">Huang T</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Khoury+JD%22">Khoury JD</searchLink>; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Thakral+B%22">Thakral B</searchLink>; Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dickinson+M%22">Dickinson M</searchLink>; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Tam+C%22">Tam C</searchLink>; Alfred Health, Melbourne, VIC, Australia; Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Livak+KJ%22">Livak KJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Getz+G%22">Getz G</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.<br /><searchLink fieldCode="AU" term="%22Neuberg+D%22">Neuberg D</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Feugier+P%22">Feugier P</searchLink>; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Kharchenko+P%22">Kharchenko P</searchLink>; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Wierda+W%22">Wierda W</searchLink>; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Olsen+LR%22">Olsen LR</searchLink>; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Jain+N%22">Jain N</searchLink>; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Wu+CJ%22">Wu CJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: Catherine_wu@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2023 Oct 09; Vol. 41 (10), pp. 1803-1816.e8. <i>Date of Electronic Publication: </i>2023 Sep 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37738974
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ccell.2023.08.013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1803
    Titles:
      – TitleFull: ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parry EM
      – PersonEntity:
          Name:
            NameFull: Lemvigh CK
      – PersonEntity:
          Name:
            NameFull: Deng S
      – PersonEntity:
          Name:
            NameFull: Dangle N
      – PersonEntity:
          Name:
            NameFull: Ruthen N
      – PersonEntity:
          Name:
            NameFull: Knisbacher BA
      – PersonEntity:
          Name:
            NameFull: Broséus J
      – PersonEntity:
          Name:
            NameFull: Hergalant S
      – PersonEntity:
          Name:
            NameFull: Guièze R
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Johnson C
      – PersonEntity:
          Name:
            NameFull: Long JM
      – PersonEntity:
          Name:
            NameFull: Yin S
      – PersonEntity:
          Name:
            NameFull: Werner L
      – PersonEntity:
          Name:
            NameFull: Anandappa A
      – PersonEntity:
          Name:
            NameFull: Purroy N
      – PersonEntity:
          Name:
            NameFull: Gohil S
      – PersonEntity:
          Name:
            NameFull: Oliveira G
      – PersonEntity:
          Name:
            NameFull: Bachireddy P
      – PersonEntity:
          Name:
            NameFull: Shukla SA
      – PersonEntity:
          Name:
            NameFull: Huang T
      – PersonEntity:
          Name:
            NameFull: Khoury JD
      – PersonEntity:
          Name:
            NameFull: Thakral B
      – PersonEntity:
          Name:
            NameFull: Dickinson M
      – PersonEntity:
          Name:
            NameFull: Tam C
      – PersonEntity:
          Name:
            NameFull: Livak KJ
      – PersonEntity:
          Name:
            NameFull: Getz G
      – PersonEntity:
          Name:
            NameFull: Neuberg D
      – PersonEntity:
          Name:
            NameFull: Feugier P
      – PersonEntity:
          Name:
            NameFull: Kharchenko P
      – PersonEntity:
          Name:
            NameFull: Wierda W
      – PersonEntity:
          Name:
            NameFull: Olsen LR
      – PersonEntity:
          Name:
            NameFull: Jain N
      – PersonEntity:
          Name:
            NameFull: Wu CJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 10
              Text: 2023 Oct 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1878-3686
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancer cell
              Type: main
ResultId 1